Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, et al. Alzheimers Dement 2024;20:3406-3415.

Read + Share

Amedeo Smart

Independent Medical Education

Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, et al. Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimers Dement 2024;20:3406-3415.
PMID: 38567735